Published January 1, 2025 | Version v1
Journal article Open

Assessment of Amniotic Fluid as a Preservation Solution in Pig Livers Undergoing Machine Perfusion

  • 1. Akdeniz Univ, Fac Med, Dept Gen Surg, Antalya, Turkiye
  • 2. Akdeniz Univ, Fac Med, Dept Histol & Embryol, Antalya, Turkiye
  • 3. Akdeniz Univ, Fac Med, Dept Biophys, Antalya, Turkiye
  • 4. Akdeniz Univ, Fac Med, Dept Med Biochem, Antalya, Turkiye
  • 5. Akdeniz Univ, Fac Med, Dept Obstet & Gynaecol, Antalya, Turkiye

Description

Introduction: Ischemia-reperfusion injury in organ transplantation highlights the need for advanced preservation techniques. This study evaluates the effectiveness of amniotic fluid (AF) compared to static cold storage and histidine-tryptophan-ketoglutarate (HTK) solution in preserving pig livers subjected to hypothermic oxygenated machine perfusion (HOMP) and ex vivo normothermic reperfusion. Materials and Methods: Fifteen pig livers underwent warm ischemia for 1 h, followed by preservation under three conditions: cold storage (group 1, n = 3), HOMP with HTK (group 2, n = 3), and HOMP with AF (group 3, n = 3). Perfusion lasted 4 h, followed by 2 h of ex vivo reperfusion. Assessments included hepatic bile production, sphingomyelin levels, reactive oxygen/nitrogen species, antioxidant capacity, tissue oxygen saturation, flow dynamics, blood gas analyses, biochemical markers, and histopathological and immunohistochemical evaluations. Results: AF-HOMP showed superior blood flow, lower vascular resistance, higher oxygen saturation, and better organ protection than HTK. Blood gas measurements demonstrated stable physiological levels after reperfusion. AF-HOMP improved bile production, sphingomyelin levels, glycogen preservation, and reduced parenchymal necrosis, hepatocyte vacuolization, and sinusoidal obstruction. Immunohistochemical analysis indicated protective effects on bile duct function, apoptosis, endothelial activation, and cell proliferation. Conclusions: AF-HOMP outperformed HTK in preserving liver tissue during warm ischemia, HOMP, and reperfusion. AF is a promising, cost-effective, and accessible alternative for liver preservation, potentially expanding donor pools and improving transplantation outcomes. Further research is warranted to explore its broader applications. 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Files

bib-a379ffaa-4606-4cc0-92aa-3a74d56ae142.txt

Files (297 Bytes)

Name Size Download all
md5:595afeb6e429cbdb25144a0e44d67109
297 Bytes Preview Download